ANXA2 and metabolic dysfunction-associated steatohepatitis: Meanwhile, inhibiting the overexpression of Anxa2 can significantly improve hepatocyte pyroptosis and liver fibrosis, either in NASH mice in vivo or LPS-induced hepatocytes in vitro.